Sight Sciences to Present at Two Upcoming Investor Conferences
Sight Sciences, Inc. announced plans to present at two investor conferences aimed at showcasing their innovative eyecare technologies. The company focuses on developing interventional solutions for eye diseases, particularly glaucoma and dry eye disease. Their products include the OMNI and SION Surgical Systems for glaucoma treatment and the TearCare System for dry eye management. Interested parties can access the presentations through the company’s investor website.
MENLO PARK, Calif., April 29, 2026 (GLOBE NEWSWIRE) — Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to transform care and improve patients’ lives, today announced plans to present at two upcoming conferences.